Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
mBio ; 5(6)2014 Dec 23.
Artigo em Inglês | MEDLINE | ID: mdl-25538191

RESUMO

UNLABELLED: Phylodynamic analysis of genome-wide single-nucleotide polymorphism (SNP) data is a powerful tool to investigate underlying evolutionary processes of bacterial epidemics. The method was applied to investigate a collection of 65 clinical and environmental isolates of Vibrio cholerae from Haiti collected between 2010 and 2012. Characterization of isolates recovered from environmental samples identified a total of four toxigenic V. cholerae O1 isolates, four non-O1/O139 isolates, and a novel nontoxigenic V. cholerae O1 isolate with the classical tcpA gene. Phylogenies of strains were inferred from genome-wide SNPs using coalescent-based demographic models within a Bayesian framework. A close phylogenetic relationship between clinical and environmental toxigenic V. cholerae O1 strains was observed. As cholera spread throughout Haiti between October 2010 and August 2012, the population size initially increased and then fluctuated over time. Selection analysis along internal branches of the phylogeny showed a steady accumulation of synonymous substitutions and a progressive increase of nonsynonymous substitutions over time, suggesting diversification likely was driven by positive selection. Short-term accumulation of nonsynonymous substitutions driven by selection may have significant implications for virulence, transmission dynamics, and even vaccine efficacy. IMPORTANCE: Cholera, a dehydrating diarrheal disease caused by toxigenic strains of the bacterium Vibrio cholerae, emerged in 2010 in Haiti, a country where there were no available records on cholera over the past 100 years. While devastating in terms of morbidity and mortality, the outbreak provided a unique opportunity to study the evolutionary dynamics of V. cholerae and its environmental presence. The present study expands on previous work and provides an in-depth phylodynamic analysis inferred from genome-wide single nucleotide polymorphisms of clinical and environmental strains from dispersed geographic settings in Haiti over a 2-year period. Our results indicate that even during such a short time scale, V. cholerae in Haiti has undergone evolution and diversification driven by positive selection, which may have implications for understanding the global clinical and epidemiological patterns of the disease. Furthermore, the continued presence of the epidemic strain in Haitian aquatic environments has implications for transmission.


Assuntos
Cólera/epidemiologia , Cólera/microbiologia , Microbiologia Ambiental , Variação Genética , Seleção Genética , Vibrio cholerae O139/classificação , Vibrio cholerae O1/classificação , DNA Bacteriano/química , DNA Bacteriano/genética , Evolução Molecular , Haiti/epidemiologia , Mutação de Sentido Incorreto , Mutação Puntual , Polimorfismo de Nucleotídeo Único , Análise de Sequência de DNA , Vibrio cholerae O1/genética , Vibrio cholerae O1/isolamento & purificação , Vibrio cholerae O139/genética , Vibrio cholerae O139/isolamento & purificação
2.
Microbes Infect ; 14(11): 968-78, 2012 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-22546527

RESUMO

No commercially live vaccine against cholera caused by Vibrio cholerae O139 serogroup is available and it is currently needed. Virulent O139 strain CRC266 was genetically modified by firstly deleting multiple copies of the filamentous phage CTXφ, further tagging by insertion of the endoglucanase A coding gene from Clostridium thermocellum into the hemagglutinin/protease gene and finally deleting the mshA gene, just to improve the vaccine biosafety. One of the derived strains designated as TLP01 showed full attenuation and good colonizing capacity in the infant mouse cholera model, as well as highly immunogenic properties in the adult rabbit and rat models. Since TLP01 lacks MSHA fimbriae, it is refractory to infection with another filamentous phage VGJφ and therefore protected of acquiring CTXφ from a recombinant hybrid VGJφ/CTXφ. This strategy could reduce the possibilities of stable reversion to virulence out of the human gut. Furthermore, this vaccine strain was impaired to produce biofilms under certain culture conditions, which might have implications for the strain survival in natural settings contributing to vaccine biosafety as well. The above results has encouraged us to consider TLP01 as a live attenuated vaccine strain having an adequate performance in animal models, in terms of attenuation and immunogenicity, so that it fulfills the requirements to be evaluated in human volunteers.


Assuntos
Vacinas contra Cólera/imunologia , Proteínas de Fímbrias/imunologia , Vibrio cholerae O139/imunologia , Administração Oral , Animais , Anticorpos Antibacterianos/imunologia , Derrame de Bactérias , Sequência de Bases , Biofilmes , Cólera/imunologia , Cólera/prevenção & controle , Vacinas contra Cólera/genética , Vacinas contra Cólera/farmacologia , Modelos Animais de Doenças , Fezes/microbiologia , Proteínas de Fímbrias/genética , Mucosa Intestinal/imunologia , Lectina de Ligação a Manose/genética , Lectina de Ligação a Manose/imunologia , Dados de Sequência Molecular , Coelhos , Ratos , Ratos Sprague-Dawley , Alinhamento de Sequência , Deleção de Sequência/genética , Estatísticas não Paramétricas , Vacinas Atenuadas/genética , Vacinas Atenuadas/imunologia , Vacinas Atenuadas/farmacologia , Vibrio cholerae O139/genética
3.
Rev Inst Med Trop Sao Paulo ; 48(2): 65-70, 2006.
Artigo em Inglês | MEDLINE | ID: mdl-16699625

RESUMO

One hundred seventy nine Vibrio cholerae non-O1/non-O139 strains from clinical and different environmental sources isolated in Brazil from 1991 to 2000 were serogrouped and screened for the presence of four different virulence factors. The Random Amplification of Polymorphic DNA (RAPD) technique was used to evaluate the genetic relatedness among strains. Fifty-four different serogroups were identified and V. cholerae O26 was the most common (7.8%). PCR analysis for three genes (ctxA, zot, ace) located of the CTX genetic element and one gene (tcpA) located on the VPI pathogenicity island showed that 27 strains harbored one or more of these genes. Eight (4.5%) strains possessed the complete set of CTX element genes and all but one of these belonged to the O26 serogroup suggesting that V. cholerae O26 has the potential to be an epidemic strain. The RAPD profiles revealed a wide variability among strains and no genetic correlation was observed.


Assuntos
Proteínas de Bactérias/genética , Vibrio cholerae O139/genética , Vibrio cholerae não O1/genética , Fatores de Virulência/genética , Brasil , DNA Bacteriano/genética , Genes Bacterianos/genética , Marcadores Genéticos , Humanos , Reação em Cadeia da Polimerase , Técnica de Amplificação ao Acaso de DNA Polimórfico , Vibrio cholerae O139/patogenicidade , Vibrio cholerae não O1/patogenicidade
4.
Mol Gen Mikrobiol Virusol ; (4): 3-13, 2004.
Artigo em Russo | MEDLINE | ID: mdl-15597566

RESUMO

"Mikrob" Russian Research Anti-Plague Institute, Saratov Studies of the genomic evolution of pathogenic bacteria became a priority research trend of modern molecular genetics. Vibrio cholerae, whose pathogenic properties are conditioned by the presence of virulence blocks of differing phylogenetic origins in 2 chromosomes, turned out to be a unique model object for studies of evolutionary transformations of genomes that are causative agents of extra dangerous infections. The molecular-and-genetic mechanisms underlying the change of biovariants and the emergence of a cholera agent of a new serogroup are in the focus of attention. Finally, the possibility that the new V. cholerae pathogenic clone originated due to horizontal genetic transfers and recombination phenomena is under discussion in the survey.


Assuntos
Evolução Molecular , Genoma Bacteriano , Vibrio cholerae/genética , Ásia/epidemiologia , Cólera/epidemiologia , Cólera/virologia , Transferência Genética Horizontal , Variação Genética , Humanos , Inoviridae/genética , Peru/epidemiologia , Recombinação Genética , Arábia Saudita/epidemiologia , Vibrio cholerae/patogenicidade , Vibrio cholerae O139/genética , Virulência/genética
5.
Int J Med Microbiol ; 292(7-8): 505-11, 2003 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-12635933

RESUMO

Vibrio cholerae O139 Bengal emerged as a second aetiologic agent of cholera in South Asia in late 1992. This new serogroup arose from a Vibrio cholerae O1 strain by deletion of the chromosomal region encoding O1 specificity and acquisition of a novel 35-kb region encoding the O139 specificity. Previous studies indicated significant phenotypic and genotypic changes in O139 isolates over the years since its first appearance. This prompted us to study possible polymorphism in the 35-kb novel region encoding the O139 specificity. A total of 17 V. cholerae O139 isolates originating from different countries and years in South Asia and China, and a single unrelated V. cholerae O139 isolate from Argentina were studied. The 35-kb chromosomal region was amplified as two fragments of 12 and 23 kb in an extended PCR from all isolates. These amplicons were then treated separately with seven different restriction enzymes and separated by agarose gel electrophoresis. The South Asian and Chinese isolates gave identical patterns for the same enzymes, but different patterns for different enzymes, thus exhibiting no polymorphism in the 35-kb region. However, the Argentine isolate gave distinct patterns for most of the enzymes confirming its different origin. This data indicated that the portion of the chromosome encoding the O139 antigen specificity is highly conserved. As found in previous studies, the early O139 isolates were resistant to trimethoprim-sulfamethoxazole (TMP-SMX) and vibriostatic compound, O/129, and CAMP- haemolysin positive. The isolates of later years diverged exhibiting different patterns by pulsed-field gel electrophoresis (PFGE), and becoming susceptible to TMP-SMX and O/129, and CAMP-haemolysin negative.


Assuntos
DNA Bacteriano/genética , Antígenos O/genética , Polimorfismo Genético , Vibrio cholerae O139/genética , Antibacterianos/farmacologia , Argentina , Ásia , China , Cólera/microbiologia , Eletroforese em Gel de Campo Pulsado , Hemólise , Humanos , Antígenos O/química , Antígenos O/metabolismo , Pteridinas/farmacologia , Combinação Trimetoprima e Sulfametoxazol/farmacologia , Vibrio cholerae O139/classificação , Vibrio cholerae O139/imunologia , Vibrio cholerae O139/isolamento & purificação
6.
Vaccine ; 21(11-12): 1282-91, 2003 Mar 07.
Artigo em Inglês | MEDLINE | ID: mdl-12559810

RESUMO

The hemagglutinin/protease (HA/P) seems to be an attractive locus for the insertion of heterologous tags in live cholera vaccine strains. A deltaCTXphi spontaneous mutant derived from a pathogenic strain of O139 Vibrio cholerae was sequentially manipulated to obtain hapA Colon, two colons celA derivatives which were later improved in their environmental safety by means of a thyA mutation. All the strains here obtained showed similar phenotypes in traits known to be remarkable for live cholera vaccines irrespective of their motility phenotypes, although the hapA mutants had a 10-fold decrease in their colonisation capacity compared with their parental strains in the infant mouse cholera model. However, the subsequent thyA mutation did not affect their colonisation properties in the same model. These preliminary results pave the way for further clinical assays to confirm the possibilities of these vaccine prototypes as safe and effective tools for the prevention of O139 cholera.


Assuntos
Vacinas contra Cólera/imunologia , Antígenos O/imunologia , Vibrio cholerae O139/imunologia , Animais , Anticorpos Antibacterianos/biossíntese , Anticorpos Antibacterianos/imunologia , Cápsulas Bacterianas/biossíntese , Cápsulas Bacterianas/imunologia , Celulase/genética , Cólera/prevenção & controle , Toxina da Cólera/biossíntese , Toxina da Cólera/genética , Clostridium/genética , Resistência a Medicamentos , Farmacorresistência Bacteriana Múltipla , Genes Sintéticos , Testes de Hemaglutinação , Imunoglobulina G/biossíntese , Imunoglobulina G/imunologia , Metaloendopeptidases/genética , Mutagênese Insercional , Coelhos , Segurança , Estreptomicina/farmacologia , Combinação Trimetoprima e Sulfametoxazol/farmacologia , Vibrio cholerae O139/efeitos dos fármacos , Vibrio cholerae O139/enzimologia , Vibrio cholerae O139/genética
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA